Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.43
-0.31 (-4.60%)
Oct 2, 2026, 4:08 PM HKT

Medlive Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
340.54334.34315.15242.3117.3240.62
Depreciation & Amortization
23.9717.7513.29.2285.91
Other Amortization
3.333.332.40.160.990.24
Loss (Gain) From Sale of Assets
0.010.01-00.090.09
Loss (Gain) on Equity Investments
----0.01-0.010
Stock-Based Compensation
0.892.345.6710.4217.2514.26
Provision & Write-off of Bad Debts
1.841.840.510.51-0.230.51
Other Operating Activities
-154.32-174.85-200.04-182.74-56.6410.66
Change in Accounts Receivable
-71.09-80.51-19.44-16.32-25.05-31.71
Change in Inventory
--0.10.1-0.11-0.09
Change in Accounts Payable
19.138.42-0.916.25-4.17-0.75
Change in Other Net Operating Assets
-27.321.86-8.3231.9819.754.7
Operating Cash Flow
135.86134.54108.32101.8777.1944.43
Operating Cash Flow Growth
-12.15%24.21%6.33%31.97%73.72%-59.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.95-11.46-11.96-0.75-1.35-1.97
Sale of Property, Plant & Equipment
--0.02---
Cash Acquisitions
-7.62-13.87-10.03-56.39-42.6-52.95
Sale (Purchase) of Intangibles
-0.43-1.37-8.92-31.78-6.14-
Investment in Securities
-199.2711.37-35.64-700.03-3,5800.03
Other Investing Activities
186.96236.02177.5515444.234.36
Investing Cash Flow
-22.31220.68111.02-634.95-3,586-50.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----6.45
Total Debt Issued
-----6.45
Short-Term Debt Repaid
------6.45
Long-Term Debt Repaid
--11.34-12.92-5.54-5.01-3.76
Lease Payments
-8.94-11.34-12.92-5.54-5.01-3.76
Total Debt Repaid
-8.94-11.34-12.92-5.54-5.01-10.22
Net Debt Issued (Repaid)
-8.94-11.34-12.92-5.54-5.01-3.76
Issuance of Common Stock
2.211.582.255.9404,033
Repurchase of Common Stock
----0.68--
Common Dividends Paid
-190.26-185.56-179.04-124.69-12.13-92
Other Financing Activities
-17.1-6.12-8.18-8.16-5.24-145.33
Financing Cash Flow
-214.1-201.45-197.89-133.13-22.383,792

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-193.14-88.1657.6363.06329.89-53.93
Net Cash Flow
-293.6865.6179.08-603.15-3,2013,732

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
133.91123.0796.36101.1275.8442.47
Free Cash Flow Growth
0.19%27.72%-4.71%33.32%78.60%-61.54%
Free Cash Flow Margin
20.75%19.16%17.25%24.54%24.15%14.93%
Free Cash Flow Per Share
0.180.170.130.140.100.07
Levered Free Cash Flow
71.5362.446.0448.9643.6164.42
Unlevered Free Cash Flow
71.8362.7446.5349.1943.9464.75
Free Cash Flow After Leases
124.97111.7383.4495.5770.8338.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.480.550.790.360.530.54
Cash Income Tax Paid
7.5612.211.0211.819.3314.16
Change in Working Capital
-79.26-50.23-28.5722.01-9.57-27.85